Day: August 14, 2025

Maui Land & Pineapple Company, Inc. Reports Fiscal Second Quarter 2025 Results

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

KAPALUA, Hawai‘i, Aug. 14, 2025 (GLOBE NEWSWIRE) — Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the quarter ended June 30, 2025. “The Company’s strong financial performance and significant revenue growth in the first half of 2025 validate our path to unlock value by maximizing the productivity of our land and commercial properties,” said Race Randle, CEO, Maui Land & Pineapple Company, Inc. “We continue to resolve legacy responsibilities and market non-strategic parcels for sale to fund projects and land improvements. Throughout the second quarter, we intentionally deployed capital to grow and diversify revenue streams, including the investment in materials and labor to launch our agave venture by planting blue weber agave on underutilized croplands in Upcounty, Maui. In addition,...

Flagship Communities Real Estate Investment Trust Expands Presence in Kentucky With Acquisition of 504-lot Manufactured Housing Community

Written by Customer Service on August 14, 2025. Posted in Mergers And Acquisitions.

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced it has acquired, from Empower Park, LLC (“Empower”), a 504-lot manufactured housing community (“MHC”) located in Georgetown, Kentucky (the “Acquisition”). The Acquisition is expected to be accretive to the REIT’s adjusted funds from operations (“AFFO”) per Unit and will be funded using cash on hand along with approximately $17 million in assumed debt that carries an average interest rate of 3.5%. Since 2022, Empower has made significant improvements to the MHC including the removal of approximately 50 older homes, the installation of new amenities, the re-installation of all new sewer...

Range Impact Reports 2Q 2025 Financial Results

Written by Customer Service on August 14, 2025. Posted in Public Companies.

Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for the second quarter ended June 30, 2025. Range Impact’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 was filed with the Securities and Exchange Commission on August 14, 2025 and is available for viewing at https://rangeimpact.com/investors/. Since the information provided in this press release is limited to selected financial and operational information, shareholders and interested parties are encouraged to read the Company’s full Form 10-Q available on its website. Michael Cavanaugh, Range Impact’s CEO, states, “Our second quarter results highlight the continued...

XWELL Reports Second Quarter 2025 Results

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing critical biosecurity support to building tech-forward wellness spaces in transportation hubs and local communities, XWELL currently is on a growth trajectory. Through its portfolio of in-airport and off-airport brands, the Company is reimagining what it means to access wellness. Operating HighlightsRevenue for the 2025 second quarter totaled $7.7 million Cost of sales decreased approximately 5% from the 2024 second quarter General and administrative expenses decreased by approximately 9% from the 2024 second quarter Named the official wellness spa of the Orlando...

Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

BOSTON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, Pulmonary Arterial Hypertension (“PAH”), today reported financial results for the quarter ended June 30, 2025 and highlighted recent developments. “During our second quarter of 2025, we continued to position the Company to advance IKT-001 toward a late-stage clinical trial in PAH,” said Mark Iwicki, Chief Executive Officer of Inhibikase. “We have now finalized our study protocol, and we expect to initiate our Phase 2b clinical study of IKT-001, our re-engineered prodrug of imatinib mesylate, in PAH in the second half of 2025.” Multiple studies including both Phase 2 and the Phase 3 IMPRES...

Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-year Invivyd’s target of near-term profitability (1H 2025) was not met but remains possible with the upcoming respiratory virus season Announced alignment with U.S. FDA on rapid pathway to full approval (BLA) of vaccine alternative monoclonal antibody candidate VYD2311 to protect American adults and adolescents from COVID-19 Announced attractive safety profile and pharmacokinetics data for VYD2311 from our pre-pivotal first-in-human clinical trial, including 76-day observed half-life for IM route of administration, allowing for potential long-term protectionWALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended June 30, 2025, and provided...

Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

FDA confirms requirement for confirmatory study of roluperidone for the treatment of negative symptoms in schizophrenia Evaluation of strategic alternatives BURLINGTON, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today provided business updates. FDA Discussions & Roluperidone Update The Company has had multiple interactions with the FDA following receipt of the Complete Response Letter (CRL) for its New Drug Application (NDA) in February 2024 and the FDA has confirmed the requirement for an additional confirmatory clinical trial to address the deficiencies cited in the CRL and resubmit the NDA. As in the two previous studies (C03 and C07), the required confirmatory...

Actelis Networks Reports Second Quarter 2025 Financial Results and Operational Update

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

FREMONT, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today reported financial results for the second quarter ended June 30, 2025. “We navigated a dynamic market environment in the second quarter, while laying the groundwork for improved growth ahead, primarily in our Federal and Military verticals where we are awaiting sizeable business that was delayed in Q2 and is expected in Q3. In addition, we have accelerated and expanded our MDU market penetration efforts in more countries and more verticals,”, said Tuvia Barlev, Chairman and CEO of Actelis. “We grew 31% in revenues sequentially vs. Q1 and we are executing multiple comprehensive...

Beam Global Announces Second Quarter 2025 Operating Results

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation, energy security and smart city infrastructure, today announced its second quarter results for the period ended June 30, 2025. Financial Highlights12% Revenue increase from Q1 2025 to Q2 2025 60% of Revenues from Non-Government Commercial Entities YTD June 30, 2025 37% of revenues from International operations YTD June 30, 2025 Positive GAAP Gross Margin 20% for Q2 2025, a 4-percentage point increase over Q2 2024 Adjusted non-GAAP Gross Margin, net of non-cash costs 30% for Q2 2025, a 12-percentage point increase over Q2 2024 Operating costs reduced by $1.2 million in Q2 2025 compared to Q2 2024 Backlog of $7M Debt free and...

Intermap Reports Second Quarter 2025 Results

Written by Customer Service on August 14, 2025. Posted in Earnings Releases And Operating Results.

Operating cash flow grew 22% in the first half of the year Company reaffirms projected 2025 revenue of $30–35 million and 28% EBITDA margin Conference call today at 5:00 pm ET to discuss results DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial intelligence solutions, today announced its financial results for the three months ended June 30, 2025. Second quarter revenue declined year over year from $3.6 million to $3.0 million due to timing effects from Indonesia and a commercial contract. The Company generated $2.1 million of operating cash flow during the quarter compared with a use of $500 thousand in the second quarter of 2024. Operating cash flow for the six months ended June 30, 2025 of $1.4 million increased 22% over the...

Day: August 14, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals